SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Daily Briefing

Weekly review: The 'very impressive' trial results of a new weight-loss drug


What overturning Roe v. Wade could mean for health care providers, severe Covid-19 is like ageing 20 years, and more.

50+ pounds of weight loss: The 'very impressive' trial results of a new drug (Monday, May 2)

Eli Lilly on Thursday announced that its new experimental weight-loss drug caused clinical trial patients with obesity to lose up to 22.5% of their body weight, or more than 50 pounds.

Supreme Court may overturn Roe v. Wade, draft opinion shows (Tuesday, May 3)

The Supreme Court appears ready to overturn the 1973 Roe v. Wade decision, which found that the U.S. Constitution protects abortion rights, as well as the 1992 Planned Parenthood v. Casey decision, which largely reaffirmed those rights, according to a leaked draft opinion obtained by Politico.

What overturning Roe v. Wade could mean for health care providers (Wednesday, May 4)

As a draft opinion suggests the Supreme Court may overturn Roe v. Wade, the health care industry faces uncertain implications. Explore our interactive map of the legal landscape in the states, and learn more about the confusing patchwork of laws providers could need to navigate.

Severe Covid-19's brain impact is like aging 20 years, study suggests (Thursday, May 5)

Cognitive impairment resulting from severe Covid-19 is equivalent to 20 years of aging and losing 10 IQ points, according to a recent study published in eClinicalMedicine.

Roe v. Wade's future is unclear. Are you ready to answer these questions? (Friday, May 6)

Health care leaders have a short window—before the Supreme Court formally rules in a pending case that could overturn Roe v. Wade—to prepare for potential implications for patients and the industry. Here are the most critical questions leadership teams should be considering, according to Advisory Board's Rachel Woods and Alex Polyak.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.